Treating SARS-CoV-2 Omicron variant infection by molnupiravir for pandemic mitigation and living with the virus: a mathematical modeling study

Treating severe COVID-19 patients and controlling the spread of SARS-CoV-2 are concurrently important in mitigating the pandemic. Classically, antiviral drugs are primarily developed for treating hospitalized COVID-19 patients with severe diseases to reduce morbidity and/or mortality, which have lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qinyue, Bao, Chunbing, Ji, Yunpeng, Li, Pengfei, Ma, Zhongren, Wang, Xinwei, Meng, Qingchun, Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071263/
https://www.ncbi.nlm.nih.gov/pubmed/37016035
http://dx.doi.org/10.1038/s41598-023-32619-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071263/
https://www.ncbi.nlm.nih.gov/pubmed/37016035
http://dx.doi.org/10.1038/s41598-023-32619-z

Ejemplares similares